The counter has had a total traded volume of 27273 shares so far with a value of Rs 3.15 crore on the NSE. It traded at a price-to-earnings multiple of 43.14 and a price-to-book ratio of 2.13.
A higher price-to-earnings ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
The price-to-book value indicates the inherent value of a company and reflects the price investors are willing to pay even for no growth in the business.
The scrip gained 26.88 per cent during the past one year, while the 30-share index advanced 49.03 per cent during the same period.
Lupin Ltd. belongs to the Pharma – Indian industry.
Promotor/FII Holding
Promoters held 46.58 per cent stake in the company as of 31-Mar-2021, while overseas investors and domestic institutional investors ownership stood at 17.87 per cent and 13.05 per cent, respectively.
Key Financials
The company reported consolidated sales of Rs 3841.32 crore for the quarter ended 31-Mar-2021, down 4.88 per cent from the previous quarter’s Rs 4038.53 crore and down 5.25 per cent from the year-ago quarter’s Rs 4054.34 crore.
Profit for the latest quarter stood at Rs 460.36 crore, up 18.15 per cent from the same quarter a year ago.
